We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Mixed sites/palliation
Poster (Digital)
Clinical
Psychiatric comorbidity impact on radiotherapy and overall survival: a matched pair analysis.
Max Peters, The Netherlands
PO-1571
Recognition and treatment recommendations of oligometastasis in multidisciplinary tumor boards
Sebastian M. Christ, Switzerland
PO-1572
Oligometastatic prostate cancer: outcomes and toxicity of stereotactic body radiation therapy (SBRT)
Elias Gomis Selles, Spain
PO-1573
Sbrt boost following prior rt: toxicity results from a phase I dose escalation study (Destroy-1)
Donato Pezzulla, Italy
PO-1578
Association of upfront treatment and survival of SVC syndrome in advanced non-small cell lung cancer
Aniwat Berpan, USA
PO-1580
Can MR-guided HIFU replace palliative radiotherapy in the treatment of painful bone metastases?
Alice Zamagni, Italy
PO-1581
AI for Radiotherapy Auto-Contouring: Current Use, Perceptions of, and Barriers to Implementation
Sumeet Hindocha, United Kingdom
PO-1582
Need for relaxation techniques in patients undergoing radiotherapy - a single center interview
Rebecca Asadpour, Germany
PO-1583
Toxicity and clinical outcomes to abdominal radiotherapy using 5 fractions for non-surgical patients
RIE ASSO, Brazil
PO-1584
Stereotactic ablative radiotherapy (SABR) for multiple oligometastases: efficacy and safety
Ciro Franzese, Italy
PO-1585
Immunomodulation by partial tumor irradiation using and carbon-ions: bystander and abscopal effects
Slavisa Tubin, Austria
PO-1586
two years of ocular proton therapy in The Netherlands, clinical results
Coen Rasch, The Netherlands
PO-1587
Palliative care assessment in glioblastoma multiforme treated in a radiotherapy department.
Mercedes Gonzalez Cantero, Spain
PO-1588
Pentoxifylline and Vitamin E for radiation-induced fibrosis in breast and head and neck patients
Martin Harpsø, Denmark
PO-1591
A Phase I Study Evaluating the Safety of SCART for Bulky metastatic or recurrent Cancer
Weisi Yan, USA
PO-1592
Real-world electronic patient reported outcome utilization in patients receiving radiation therapy
Heather Curry, USA
PO-1593
Optimizing palliative radiotherapy treatment in last 30 days of life
Jose David González, Spain
PO-1594
Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases
Federica Ferrario, Italy
PO-1595
Stereotactic body re-irradiation for bone metastases
Laura Giannini , Italy
PO-1596
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia: Single Center Experience
Federico Colombo, Italy
PO-1597
SBRT WITH CDK4/6 INHIBITORS FOR OLIGORECURRENT/OLIGOPROGRESSIVE BREAST CANCER PATIENTS
Edy Ippolito, Italy
PO-1598
Survival prognosis of elderly patients irradiated for spinal bone metastases with a new scoring tool
Nils Nicolay, Germany
PO-1600
Hypofractionated dose-intensified palliative RT: 25 Gy in 5 fractions for enhanced symptom control
Jayson Paragas, Philippines
PO-1602
Radiation therapy for hypersalivation in patients with amyotrophic lateral sclerosis
Macarena M. Teja Ubach, Spain
PO-1603
Impact of COVID-19 pandemic in our Radiation oncology department
Patricia Valencia Nieto, Spain
PO-1604
Metastatic tumor burden in cancer patients: implications for the oligometastatic spectrum theory
Sebastian M. Christ, Switzerland
PO-1606
Same-day MRI-LINAC guided single fraction radiosurgery for painful non-spine bone metastases
Eva-Maria Kretschmer, Switzerland
PO-1607
SYNERGISTIC EFFECT OF STEREOTACTIC RADIOTHERAPY AND IMMUNOTHERAPY: AN ITALIAN MULTICENTRIC STUDY
Giuseppe Fanetti, Italy
PO-1608
Lung metastasis treatment with Stereotactic Body Radiation Therapy: a single institution experience
Susana Costa, Portugal
PO-1609
SBRT AS A RADICAL LOCAL TREATMENT IN OLIGOMETASTATIC DISEASE
Macarena M. Teja Ubach, Spain
PO-1610
PAROXYSMAL ATRIAL FIBRILLATION IN ELDERLY: LINAC-BASED SBRT ARRHYTHMIA RADIOABLATION PHASE 2 TRIAL
Alba Fiorentino , Italy
PO-1611
Inter and intrafraction motion in SABR patients treated for bone oligometastasis
Helen Hawes, United Kingdom
PO-1612
Is lumbosacral plexus delineation a must in modern pelvic radiotherapy ?
zineb DAHBI, Morocco
PO-1613